Loading organizations...
§ Venture Capital
The Yangtze River-CMB International Industry Fund operates as a venture capital vehicle, strategically deploying capital into high-growth sectors. It identifies and backs innovative enterprises, particularly those developing advanced technologies within life sciences, as evidenced by its participation in significant gene therapy funding rounds. The fund's approach centers on fostering technological advancement and industrial upgrading through targeted investments.
The fund's establishment reflects a significant collaborative endeavor, bringing together the financial expertise of CMB International, the international arm of China Merchants Bank, with other regional industrial development entities. While specific founding details are often intertwined with broader Yangtze River industrial initiatives, its emergence in the mid-2010s marked a concerted effort to channel investment into key strategic industries within the region and beyond.
The fund's portfolio companies, primarily innovative startups and growing firms, benefit from its capital infusion and strategic guidance. Yangtze River-CMB International Industry Fund envisions itself as a pivotal force in cultivating future industry leaders, driving economic transformation by supporting enterprises poised for substantial impact and sustainable growth in evolving global markets.
Yangtze River-CMB International Industry Fund has 1 tracked investment across 1 company. The latest tracked deal is $95.0M Series C in Neurophth Therapeutics in August 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 11, 2023 | Neurophth Therapeutics | $95.0M Series C | Hubei KTLC, Wuhan, Wuhan HI Tech Holding Group, Wuhan Optical Valley Financial Holding Group, Yangtze River CMB International Industry Fund | CMG SDIC Capital, Silicon Paradise Asset Management, Yangtze River Industry Fund |